Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-28 @ 2:46 PM
Study NCT ID:
NCT04613466
Status:
UNKNOWN
Last Update Posted:
2020-11-13
First Post:
2020-10-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Prevelance of Pulmonary Manifestation in Patients With Inflammatory Bowel Disease
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 60}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'NOT_YET_RECRUITING', 'startDateStruct': {'date': '2020-12-01', 'type': 'ESTIMATED'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2020-11', 'completionDateStruct': {'date': '2022-06-01', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2020-11-10', 'studyFirstSubmitDate': '2020-10-28', 'studyFirstSubmitQcDate': '2020-10-28', 'lastUpdatePostDateStruct': {'date': '2020-11-13', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2020-11-03', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2021-12-01', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'The presence of pulmonary manifestations in IBD patients', 'timeFrame': '1 year'}]}, 'oversightModule': {'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['The Prevelance and Complications of Pulmonary Manifestations in Patients With Inflammatory Bowel Disease']}, 'descriptionModule': {'briefSummary': 'Bronchopulmonary manifestations signs and symptoms are variable extraintestinal manifestations of IBD.', 'detailedDescription': 'Several cases like bronchiactsis, bronchitis, tracheobronchitis and broncholitis. None of this complications are specific for either crohns or ulcerative , however the majority of cases are related to ulcerative colitis.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '60 Years', 'minimumAge': '18 Years', 'genderBased': True, 'samplingMethod': 'PROBABILITY_SAMPLE', 'studyPopulation': 'All patients diagnosed IBD either male or female age 18 to 60 years', 'genderDescription': 'rural or urban', 'eligibilityCriteria': 'Inclusion Criteria:All patients diagnosed ulcerative colitis and crohns disaese on conventional treatment and biological treatment -\n\nExclusion Criteria:no exclusion criteria\n\n\\-'}, 'identificationModule': {'nctId': 'NCT04613466', 'briefTitle': 'The Prevelance of Pulmonary Manifestation in Patients With Inflammatory Bowel Disease', 'organization': {'class': 'OTHER', 'fullName': 'Assiut University'}, 'officialTitle': 'The Prevelance of Pulmonary Manifestations in Patients With Inflammatory Bowel Disease', 'orgStudyIdInfo': {'id': 'Gateroentrolgy unit'}}, 'contactsLocationsModule': {'centralContacts': [{'name': 'Hussein Elamin', 'role': 'CONTACT', 'email': 'sehshammam@gmail.com', 'phone': '01004084187'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Assiut University', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'clinical doctor of internal medicine', 'investigatorFullName': 'Hayam Fathy Nasr', 'investigatorAffiliation': 'Assiut University'}}}}